Young man, 21 years of age. type 1 diabetes since 9 years of age. Has not been to see hcp for a year. States he doesn’t like people interrogating him, but came in because he needs his insulin. States he doesn’t check his glucose because he can tell what it is. Tired of having type 1 diabetes and tired of checking numbers. A1C in office--10.2%.
Read More »Factors Related to C-peptide Levels Following Type 1 Diabetes Diagnosis In Type 1 Children
Young patients with low BMIs, C-peptide levels, and significant symptoms at onset of diabetes at higher risk of undergoing rapid C-peptide decline.
Read More »Exercise to Lower Your Risk of Dying (Prematurely) with Type 1 Diabetes
By Sheri R. Colberg, PhD: Much of the research on length of life for individuals living with type 1 diabetes is pessimistic, which makes a new study released recently a breath of fresh air. Data were collected for the ongoing nationwide, multicenter, Finnish Diabetic Nephropathy (FinnDiane) Study that tracked the death rate of 2,639 study participants.
Read More »Dapagliflozin Added To Insulin For People with Type 1
Trial shows HbA1c reduced, hypoglycemia and DKA similar across study participants.
Read More »An Overview of EASD 2017
By Guest Writer David Kliff, Diabetic Investor: As we were getting ready to disembark the plane when it arrived in Lisbon I asked a long-term consultant to the diabetes industry why he comes to EASD. “I like to come here because what they have here will show up in our country in two years” was his response. Given what we witnessed at EASD there isn’t much to look forward to in 2019.
Read More »Two New Treatments Offer Type 1 Patients Greater Weight Loss and A1c Reduction
Trial results promising, but DKA still a concern with use of new once-daily pills.
Read More »Increasing Incidence of Type 1 Diabetes In Children
Philadelphia youth see rise in diagnosis; especially for African Americans, by 70%.
Read More »Metformin For T1D Benefits – REMOVAL Study
The results of the REMOVAL study were presented at the 2017 European Association for the Study of Diabetes (EASD) in Lisbon
Read More »Benefits of CGM’s for Type 1 Patients
Real-time monitoring produces significant long-term improvement in HbA1c.
Read More »CGM Use For Type 1 Pregnant Women Randomized Trial- CONCEPTT Study
Study examined effectiveness of CGM on maternal glucose control and obstetric and neonatal health outcomes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.